ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in ESSA Pharma Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −8 vs. Q4 2022
- Shares held
- 33.1M
- −277.0K (−0.8%) vs. Q4 2022
- Total value
- $98.3M
- +$14.2M (+16.9%) vs. Q4 2022
- New holders
- 5
- 11 more added
- Sold out
- 13
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 48 | $0 | 0.00% | +48 | New |
| Newbridge Financial Services Group, Inc. | 31 | $92 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $149 | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 265 | $788 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.78K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 775 | $2.00K | 0.00% | −990−56.1% | Reduced |
| TD Waterhouse Canada Inc. | 900 | $2.63K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,170 | $6.45K | 0.00% | +1,156+114.0% | Added |
| BlackRock Inc. | 2,261 | $6.71K | 0.00% | +2,261 | New |
| UBS Group AG | 3,254 | $9.66K | 0.00% | −3,268−50.1% | Reduced |
| Advisor Group Holdings, Inc. | 5,225 | $15.5K | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 6,852 | $20.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9,429 | $28.0K | 0.00% | +7,929+528.6% | Added |
| Hunting Hill Global Capital, LLC | 10,000 | $29.7K | 0.03% | −10,000−50.0% | Reduced |
| Northern Trust Corp | 12,489 | $37.1K | 0.00% | +761+6.5% | Added |
| Acadian Asset Management LLC | 15,903 | $47.0K | 0.00% | +15,903 | New |
| Geode Capital Management, LLC | 19,039 | $56.5K | 0.00% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 20,032 | $61.5K | 0.05% | +20,032 | New |
| State Street Corp | 24,852 | $73.8K | 0.00% | −109−0.4% | Reduced |
| Two Sigma Investments, LP | 49,262 | $146.3K | 0.00% | −41,941−46.0% | Reduced |
| JPMorgan Chase & Co | 59,706 | $177.0K | 0.00% | +50,955+582.3% | Added |
| Connective Capital Management, LLC | 142,727 | $423.9K | 0.63% | +142,727 | New |
| D. E. Shaw & Co., Inc. | 172,221 | $511.5K | 0.00% | −78,164−31.2% | Reduced |
| CIBC World Markets Inc. | 208,791 | $620.0K | 0.00% | +43,150+26.1% | Added |
| Two Sigma Advisers, LP | 223,800 | $664.7K | 0.00% | +51,700+30.0% | Added |
| Ally Bridge Group (NY) LLC | 236,583 | $702.7K | 0.92% | −574,972−70.8% | Reduced |
| Driehaus Capital Management LLC | 264,571 | $785.8K | 0.01% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 356,500 | $1.05M | 0.12% | −18,500−4.9% | Reduced |
| Millennium Management LLC | 419,067 | $1.25M | 0.00% | +244,592+140.2% | Added |
| Rock Springs Capital Management LP | 524,944 | $1.56M | 0.04% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $3.10M | 0.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,198,337 | $3.56M | 0.07% | +833,037+228.0% | Added |
| Morgan Stanley | 3,105,215 | $9.22M | 0.00% | +1,098,738+54.8% | Added |
| Soleus Capital Management, L.P. | 4,145,117 | $12.3M | 1.53% | +275,725+7.1% | Added |
| PFM Health Sciences, LP | 4,161,461 | $12.4M | 0.57% | +317,129+8.2% | Added |
| Bellevue Group AG | 7,898,583 | $23.5M | 0.34% | 00.0% | Unchanged |
| BVF Inc | 8,748,629 | $26.0M | 0.95% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,855,400−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −605,141−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −33,389−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −34,624−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −34,086−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −20,784−100.0% | Sold out |
| One Wealth Advisors, LLC | 0 | $0 | 0.00% | −8,333−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,751−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −241−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −113−100.0% | Sold out |